Cancer Care Associates Medical Oncology

Bethlehem, Pennsylvania 18015

0 studies enrolling now · 2 studies all time

What they study most

BRAF or NRAS Mutant Metastatic Melanoma, Non-small Cell Lung Cancer

Studies at this site

• A Phase II Study of Single Agent MEK162 in Patients With Advanced Melanoma — Completed
• A Study of Erlotinib (Tarceva) After Surgery With or Without Adjuvant Chemotherapy in Non-Small Cell Lung Carcinoma (NSCLC) Patients Who Have Epidermal Growth Factor Receptor (EGFR) Positive Tumors — Completed